WinstonWınston
Back
Siemens Healthineers AG logo

Siemens Healthineers AG

SMMNY
53
Medical - Devices · Healthcare
Exchange
Other OTC
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Weak
Cash Flow
Strong
Stability
Strong
Valuation
Strong
Dividends
Good

Winston Score History

The full picture

Siemens Healthineers makes medical equipment and software used in hospitals and clinics around the world. Its core products include MRI machines, CT scanners, X-ray systems, and laboratory diagnostics tools that help doctors detect and diagnose diseases. The company is one of the largest medical technology companies in the world and is a majority-owned subsidiary of the German industrial giant Siemens AG.

The company earns money by selling imaging hardware, diagnostic equipment, and software, while also generating recurring revenue from service contracts, reagents, and software licenses. Siemens Healthineers operates globally, with strong presence in Europe, North America, and Asia, and reported revenues of roughly €22 billion in its most recent fiscal year. Its competitive moat comes from deep integration into hospital workflows and high switching costs, since replacing imaging systems is expensive and disruptive. The key growth driver is expanding its cancer treatment business through its Varian radiation therapy division, though rising competition from GE HealthCare and Philips remains an ongoing risk.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
42.5%
Healthy — 42.5% gross margin
Profit after running costs
Operating Margin
16.6%
Healthy — 16.6% operating margin
Return on the money invested
ROCE
9.5%
Below par — 9.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-6.5%
Shrinking sales (-6.5% YoY)
Profit growth
EPS YoY
-10.2%
Earnings shrinking (-10.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
140%
Turns 140% of profit into real cash
Spare cash per sale
FCF Margin
10.5%
Modest free cash flow (10.5%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.76
Moderate — manageable debt (0.76)
Covers its interest
Interest Cover
9.70x
Comfortably covers interest (9.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
20.3x
no trend
Growth-priced — P/E 20.3

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+6.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (20.3 → 13.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.85%
no trend
Moderate income — 2.85% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+7.1%
no trend
Dividend growing modestly (7.1% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial